Supernus Pharmaceuticals SUPN reported its Q3 earnings results on Wednesday, November 3, 2021 at 04:00 PM.
Here's what investors need to know about the announcement.
Supernus Pharmaceuticals their estimated earnings by 73.91%, reporting an EPS of $0.4 versus an estimate of $0.23, which surprised analysts.
Revenue was up $6,671,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.23, which was followed by a 2.17% drop in the share price the next day.
Here's a look at Supernus Pharmaceuticals's past performance:
|Quarter||Q2 2021||Q1 2021||Q4 2020||Q3 2020|
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.